Most recent posts

  XML Feeds

Search

« MedBen Rx Strategies Help Employers Face Pricing ChallengesFraker and Fellow SPBA Members Meet with Congressional Offices »

Prostate Cancer Screening Guidelines Questioned

05/03/18

  10:52:00 pm, by MedBen5   , 174 words,  
Categories: News, Wellness, Cancer

Prostate Cancer Screening Guidelines Questioned

cancer definition

The pros and cons of prostate cancer screening have been debated since the U.S. Preventive Services Task Force (USPSTF) advised against the testing for most men in 2012 – and consequences of that advice may be surfacing.

In a recent Medscape commentary, Dr. Arefa Cassoobhoy called attention to recent studies that found decreases in incidences of low-grade disease, but increases in more aggressive prostate cancer. She suggests that the increases could be adverse consequences of the USPSTF's recommendation.

MedBen WellLiving currently follows American Cancer Society guidelines, which recommend that men age 50 and above (or younger, in cases of high risk) should discuss testing options with their family doctor. Decision about testing should be based on family history, lifestyle, and symptoms. However, some WellLiving clients do encourage all male plan members of appropriate age to get tested, so be sure to check your plan's guidelines before scheduling your annual wellness exam.

MedBen clients who have any questions about USPSTF preventive care requirements under the Affordable Care Act are welcome to contact Compliance Manager Erin Kelly at ekelly@medben.com.

No feedback yet